• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钍造影剂患者体内钍的全身沉积,特别关注次要储存部位。

Systemic deposits of thorium in thorotrast patients with particular reference to sites of minor storage.

作者信息

Ishikawa Y, Mori T, Kato Y, Machinami R, Priest N D, Kitagawa T

机构信息

Department of Pathology, Cancer Institute, Tokyo, Japan.

出版信息

Radiat Res. 1993 Aug;135(2):244-8.

PMID:8367596
Abstract

It is well established that injected Thorotrast is deposited in the liver, spleen, bone marrow, and lymph nodes, but accumulations in organs with lower macrophage activity have previously been given little attention. In this work, neutron activation analysis has been used to investigate concentrations of thorium in autopsy samples taken at sites of major and minor deposition in 24 Thorotrast patients. In the latter category, the highest values were found in the testis [40 x 10(-6) g/g(wet)], followed by those in the adrenal gland, gallbladder, lung, and pancreas. The resulting alpha-particle dose rates (mGy/year) are tentatively estimated to be 8.5 to the testis, 5.5 to the gallbladder, and 5.3 to the lung. These results may be relevant to the residual excess mortality among Thorotrast patients after diseases of the principal organs of deposition have been excluded; they also support previous indications that thorium deposited in pulmonary tissues is responsible for an important component of the total dose to the lung. In another context, our data may bear on the connection, postulated elsewhere, between exposure to alpha-particle emitters and elevated incidence of leukemia in the children of workers engaged in the reprocessing of nuclear fuel.

摘要

众所周知,注入的钍造影剂会沉积在肝脏、脾脏、骨髓和淋巴结中,但此前很少有人关注巨噬细胞活性较低的器官中的积累情况。在这项研究中,中子活化分析被用于调查24名钍造影剂患者主要和次要沉积部位尸检样本中的钍浓度。在后者中,睾丸中的钍浓度最高[40×10(-6)克/克(湿重)],其次是肾上腺、胆囊、肺和胰腺。初步估计,由此产生的α粒子剂量率(毫戈瑞/年)分别为:睾丸8.5、胆囊5.5、肺5.3。这些结果可能与排除主要沉积器官疾病后钍造影剂患者中剩余的额外死亡率有关;它们还支持了先前的观点,即沉积在肺组织中的钍是肺部总剂量的重要组成部分。在另一种情况下,我们的数据可能与其他地方假设的α粒子发射体暴露与从事核燃料后处理的工人子女白血病发病率升高之间的联系有关。

相似文献

1
Systemic deposits of thorium in thorotrast patients with particular reference to sites of minor storage.钍造影剂患者体内钍的全身沉积,特别关注次要储存部位。
Radiat Res. 1993 Aug;135(2):244-8.
2
Revised organ partition of thorium-232 in thorotrast patients.钍造影剂患者中钍-232的器官分区修订
Radiat Res. 1999 Dec;152(6 Suppl):S102-6.
3
Determination of thorium in organs from thorotrast patients by inductively coupled plasma mass spectroscopy and x-ray fluorescence.通过电感耦合等离子体质谱法和X射线荧光法测定钍造影剂患者器官中的钍。
Radiat Res. 1999 Dec;152(6 Suppl):S97-S101.
4
Partition of thorium between organs of monkeys injected with thorotrast: implications for alpha-particle dosimetry.注射钍胶体的猴子各器官中钍的分布:对α粒子剂量测定的意义
Radiat Res. 1998 Sep;150(3):369-72.
5
Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation.体内沉积放射性核素与外照射对人类致癌作用的定量比较。
Int J Radiat Biol. 2003 Jan;79(1):1-13.
6
Tissue distribution and steady state activity ratios of Th232 and daughters in man following intravascular injection of thorotrast.
RISO Rep. 1973 Jun(294):14-30.
7
Determination of thorium series nuclides in thorotrast patients.钍造影剂患者中钍系核素的测定。
Radioisotopes. 1978 Sep;27(9):449-503.
8
Quantitative CT for determination of thorium in thorotrast patients.定量CT用于钍造影剂患者体内钍的测定。
Radiat Med. 1989 May-Jun;7(3):135-8.
9
Tissue distribution of Thorotrast and role of internal irradiation in carcinogenesis.
Oncol Rep. 2004 Oct;12(4):733-8.
10
Distribution of thorotrast and its daughter nuclides and estimation of absorbed dose in the human organs.
RISO Rep. 1973 Jun(294):72-80.

引用本文的文献

1
Estimating the Risk for Secondary Cancer After Targeted α-Therapy with At Intraperitoneal Radioimmunotherapy.评估腹腔内放射性免疫治疗靶向 α 治疗后继发癌症的风险。
J Nucl Med. 2023 Jan;64(1):165-172. doi: 10.2967/jnumed.121.263349. Epub 2022 Jul 7.
2
Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development.将危险因素与胆管癌发生相联系的分子机制
Cancers (Basel). 2022 Mar 11;14(6):1442. doi: 10.3390/cancers14061442.
3
Lack of apparent excess of malignant mesothelioma but increased overall malignancies of peritoneal cavity in Japanese autopsies with Thorotrast injection into blood vessels.
在日本尸检中,向血管内注射钍造影剂后,恶性间皮瘤无明显过多,但腹膜腔总体恶性肿瘤有所增加。
J Cancer Res Clin Oncol. 1995;121(9-10):567-70. doi: 10.1007/BF01197771.